Clinical Trials
12 trialsNCT02808247 2021-09-20
ANITA
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT02929394 2020-09-02
Trabectedin Maintenance Post 1st-line in STS
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00003054 2018-04-12
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00427414 2015-04-29
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 1 Terminated
NCT00072280 2014-09-30
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Children's Oncology Group
Phase 2 Terminated
NCT01189253 2014-08-08
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated
NCT00002993 2013-07-09
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00003156 2013-04-11
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00003316 2013-04-11
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00003624 2013-04-11
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00033644 2013-04-11
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00014313 2012-09-24
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated